LINC01857 overexpression results in induced lymph node metastasis, cancer cell viability, frustrating clinical outcomes and tumor growth and inhibits apoptosis in human cancers, including gastric cancer and pancreatic ductal adenocarcinoma [9, 10]. Here, LINC01857 is linked to cancer.